FDA UNTITLED_LETTER - Claremore Compounding Center - August 21, 2020

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This UNTITLED LETTER record concerns Claremore Compounding Center, with an inspection on August 21, 2020, covering drugs.

Company: Claremore Compounding Center
Inspection Date: August 21, 2020
Product Type: Drugs
Person: Monica R. Maxwell (Program Division Director)

Open in Dashboard

ID · 3e4d6dd9-166b-4fab-ba6c-25c4554b256a

Violation Codes10

21 CFR 211.166(a)21 U.S.C. 331(k)21 CFR 21121 U.S.C. 805(a)(2)(A)21 CFR 211.165(a)21 CFR 21021 CFR 216.23(a)21 U.S.C. 352(f)(1)21 U.S.C. 351(a)(2)(B)21 CFR 210.1(b)

Full citation text and observation details available on the Dashboard.